AstraZeneca books Product Sales in markets outside the United States ... Currently, AstraZeneca has a Zacks Rank #3 (Hold).

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

AstraZeneca AZN0.05%increase; green up pointing triangle said it plans to pump $2 billion in new investment into the U.S., ...

We recently compiled a list of the 10 Best ... into new therapeutic areas. Its product lineup is anchored by its oncology ...

AstraZeneca is holding crisis talks with the Chinese authorities after the arrest of its boss in the country. The ...

The company said, “Given the strength of underlying Product Sales and Alliance Revenue, as well as increased confidence in achieving ...

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

Nov 5 (Reuters) - AstraZeneca (AZN.L), opens new tab shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be ...

LONDON, Nov 6 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason ...

CEO says But is the focus on combination opportunities really an excuse for AstraZeneca to take off the pressure of proving that any of its obesity products will actually be able to deliver the ...